GEN Podcasts

Precision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene Therapies

33 min · 28. mar. 2025
episode Precision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene Therapies cover

Description

In this episode, you’ll hear a group of experts discussing base editing and how the technology is helping scientists engineer powerful cell therapies for various diseases including novel CAR-T therapies and hypoimmunogenic induced pluripotent stem cells. During the discussion, they will cover the merits of the Pin-point base editing platform, which introduces gene modifications without relying on double-strand DNA breaks, as well as how TotalSeq reagents, which confirm the safety and efficiency of editing with the Pin-point platform, support single cell multiomics analysis of edited cells. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

Comments

0

Be the first to comment

Sign up now and become a member of the GEN Podcasts community!

Get Started

2 months for 19 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

8 episodes

episode Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness. artwork

Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness.

Lentiviral vectors are gaining momentum not just as ex vivo tools but as potential in vivo therapeutic platforms. But with that shift comes a number of manufacturing challenges, including higher doses, tighter control of impurities, greater batch consistency, and scalable processes to meet both clinical and commercial needs. In this GEN Podcast, two experts from SK Pharmteco, a global CMO, address these challenges and lay out some best practices that guide the manufacture of lentiviral vectors with the requisite purity, robustness, and economic feasibility required for widespread clinical adoption. Guest speakers: Mardhani Aparajithan, Director of Manufacturing, Science and Technology, SK Pharmteco Tatiana Nanda, PhD, CTO, Cell and Gene Therapy, SK Pharmteco Moderator: Kevin Davies, PhD, Editorial Director, GEN ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

21. apr. 202635 min
episode The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera artwork

The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera

Sponsored by Seqera As data volumes in life sciences continue to grow, bioinformaticians and researchers are more dependent than ever on solutions that help them streamline workflows, manage data, and scale their research. In this timely podcast, Evan Floden, CEO and co-founder of Seqera, shares how his company is addressing these needs through Nextflow—the open-source orchestrator for scalable, reproducible, and portable scientific workflows—and Seqera Platform, a unified solution for the entire scientific data lifecycle. He also discusses how Seqera has become a widely adopted solution, trusted by 13 of the top 20 pharmaceutical companies, empowering breakthroughs in drug discovery, genomics, clinical research, and.beyond. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

11. apr. 202518 min
episode Precision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene Therapies artwork

Precision Base Editing Meets Single-Cell Multiomics to Advance Cell and Gene Therapies

In this episode, you’ll hear a group of experts discussing base editing and how the technology is helping scientists engineer powerful cell therapies for various diseases including novel CAR-T therapies and hypoimmunogenic induced pluripotent stem cells. During the discussion, they will cover the merits of the Pin-point base editing platform, which introduces gene modifications without relying on double-strand DNA breaks, as well as how TotalSeq reagents, which confirm the safety and efficiency of editing with the Pin-point platform, support single cell multiomics analysis of edited cells. ---------------------------------------- Hosted on Acast. See acast.com/privacy [https://acast.com/privacy] for more information.

28. mar. 202533 min